Navigation Links
Oncolytics Biotech(R) Inc. Collaborators Update Combination REOLYSIN(R) and Docetaxel Trial Results at Replicating Oncolytic Virus Meeting
Date:3/20/2009

bination with a standard dosage of docetaxel. Eligible patients included those who have been diagnosed with advanced or metastatic solid tumours that are refractory (have not responded) to standard therapy or for which no curative standard therapy exists.

The poster presentation will be available on the Oncolytics website today at www.oncolyticsbiotech.com.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit www.oncolyticsbiotech.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the implication of the materials presented at this meeting with respect to REOLYSIN(R), the Company's expectations related to the results of trials investigating delivery of REOLYSIN(R), the Company's analysis of the results of the REOLYSIN(R)/docetaxel trial and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize RE
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting
2. Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008
3. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering North America
4. Oncolytics Biotech Inc. Announces Issuance of 31st U.S. Patent
5. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study
6. Media Advisory - Oncolytics Biotech Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference
7. Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data
8. Oncolytics Biotech Inc. Announces U.S. Phase II Sarcoma Clinical Trial Conference Call
9. Oncolytics Biotech Inc. Announces 2008 Third Quarter Results
10. Oncolytics Biotech Inc. Announces Decision to Pursue Phase II/III Pivotal Clinical Trial
11. Oncolytics Biotech Inc. Announces Clinical Update Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Chantel Lee ’15 and Eli Capello ’15 sacrificed a ... Dr. Juan Rodriguez, Professor of Physics, in an effort to ... disease caused by changes in the blood vessels of the ... quite remarkable,” said Rodriguez. “They took on a graduate level ... together carried it to near completion in just a few ...
(Date:8/1/2014)... CHICAGO , Aug. 1. 2014 As ... U.S., the 2014 AACC Annual Meeting & Clinical Lab ... testing and patient care are introduced to the healthcare ... by the Expo,s 650 exhibitors will include the latest ... Advances in smartphones and biosensors have enabled ...
(Date:8/1/2014)... 2014 Research and Markets has ... Polymorphism (SNP) Genotyping and Analysis Market 2014-2018" report ... Single Nucleotide Polymorphism (SNP) genotyping is ... in the genome of various species. SNPs are commonly ... analysis technology can analyze thousands of SNPs and has ...
(Date:8/1/2014)... 01, 2014 Testing the mechanical ... a better understanding embryonic development. How and ... structurally and functionally distinct tissues is important because ... Prof. Todd McDevitt, Melissa Kinney, and Rabbia Saeed ... with biochemical cues to control many aspects of ...
Breaking Biology Technology:Two Centenary College Students Tackle Diabetic Retinopathy Research 2Lab-on-a-Chip Technology to Be Featured at 2014 AACC Annual Meeting & Clinical Lab Expo 2Lab-on-a-Chip Technology to Be Featured at 2014 AACC Annual Meeting & Clinical Lab Expo 3Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018 2Study Links Biomechanics and Gene Expression in Stem Cells 2
... an online application provider, have won the 2006 "Creating ... Claire Area Economic Development Corp . , ,Winners in ... LLC, an online application service provider of real estate ... of multi-oil combustion systems. , ,In addition to recognition, ...
... - In a move designed to give Wisconsin a ... announced a partnership agreement with the Wisconsin Alumni ... cell research at non-profit and academic institutions in Wisconsin ... patents held by WARF. , ,In what the administration ...
... esoteric territory, but a Madison court is taking some of ... might be giving smaller drug companies a chance to defend ... example occurred last month. After a relatively speedy trial that ... District Court for the Western District of Wisconsin first ...
Cached Biology Technology:Eau Claire business contest honors tech start ups 2Doyle, WARF announce partnership to lure stem cell companies 2Doyle, WARF announce partnership to lure stem cell companies 3With patents, Wisconsin court gaining reputation as a "rocket docket" 2With patents, Wisconsin court gaining reputation as a "rocket docket" 3With patents, Wisconsin court gaining reputation as a "rocket docket" 4
(Date:8/1/2014)... the fossil record about 200,000 years ago, but it ... and advanced tools became widespread. , A new ... Anthropology finds that human skulls changed in ways ... the same time that culture was blossoming. , "The ... rapid cultural exchange probably came at the same time ...
(Date:8/1/2014)... research will provide enormous opportunities for both biological ... replicate any other cells in the body, offering ... spinal cords, treating kidney, liver and lung diseases ... profit is staggering. Prof. Jinhui Chen from Indiana ... research still faces myriad biological, ethical, legal, political, ...
(Date:8/1/2014)... soon have a more effective way to control the ... from the National University of Singapore (NUS). , The ... Department of Pharmacology at the NUS Yong Loo Lin ... a recent PhD graduate from the Saw Swee Hock ... a common herbal-based anti-malarial drug, can be used to ...
Breaking Biology News(10 mins):Society bloomed with gentler personalities and more feminine faces 2NUS study shows effectiveness of common anti-malarial drug in controlling asthma 2
... The Center for Alternatives to Animal Testing (CAAT) at ... the National Academy of Sciences (NAS) and the authors of ... Vision and a Strategy, to receive the CAAT Recognition Award ... the 7th World Congress on Alternatives and Animal Use in ...
... thing that comes to mind when people think of Alzheimer,s ... Korea and France, this might change. That,s because these researchers ... "RanBP9" might be the key that unlocks an entirely new ... research report published online in The FASEB Journal ...
... and scientists need an informed, thoughtful, and open-minded citizenry. ... is strikingly inconsistent with the low level of scientific ... the "Year of Science," professional scientific organizations and grassroots, ... focus on the importance of science now and in ...
Cached Biology News:Scientists begin to untangle root cause of Alzheimer's disease 2How to advance scientific literacy 2How to advance scientific literacy 3
Recombinant Mouse Noggin...
...
Mouse Iduronate 2-Sulfatase Affinity Purified Polyclonal Ab Keywords: Sulfatases, Iduronate 2-Sulfatase, Mucopolysaccharidosis, Hunter Syndrome, Glycobiology Protein Family: Proteoglycan Regu...
Immunogen: Synthetic Peptide: C N(185) D G T E F G G S I Y Q K(197) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: